Apogee Therapeutics (APGE) Shares Outstanding (2022 - 2026)
Apogee Therapeutics' Shares Outstanding came in at 75.44 million for Q2 2026, up 29.1% from 58.43 million a year earlier and up 8.3% from the prior quarter.
Powered by 
Analysis
Apogee Therapeutics (APGE) Shares Outstanding (2022 - 2026) Analysis & Trends
For FY2025, Apogee Therapeutics' Shares Outstanding was 60.69 million, up 10.0% from FY2024.
- Shares Outstanding has increased in each of the last three years, with a three-year compound annual growth rate of 191.0% (FY2022 to FY2025).
- Going back by year, Shares Outstanding was 55.19 million in FY2024 (+120.7%), 25.01 million in FY2023 (+915.6%) and 2.46 million in FY2022.
- The Q2 2026 figure represents the highest quarterly Shares Outstanding in data going back to Q2 2022.
- Year-over-year, Shares Outstanding has increased for eight consecutive quarters, with growth averaging 30.0% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding ranged from 3.4% (Q2 2025) to 915.6% (Q4 2023).
- Business Quant data shows APGE's Shares Outstanding at 69.67 million (Q1 2026), 60.69 million (Q4 2025) and 58.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Apogee Therapeutics | 10.18 Bn | 7.68 Bn | - | 75.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.44 Mn |
| Mar 31, 2026 | 69.67 Mn |
| Dec 31, 2025 | 60.69 Mn |
| Sep 30, 2025 | 58.77 Mn |
| Jun 30, 2025 | 58.43 Mn |
| Mar 31, 2025 | 58.20 Mn |
| Dec 31, 2024 | 55.19 Mn |
| Sep 30, 2024 | 56.80 Mn |
| Jun 30, 2024 | 56.52 Mn |
| Mar 31, 2024 | 50.19 Mn |
| Dec 31, 2023 | 25.01 Mn |
| Sep 30, 2023 | 41.23 Mn |
| Jun 30, 2023 | 5.00 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 2.46 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 1.25 Mn |
API Access
Apogee Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=APGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "APGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=APGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();